Monoclonal ucGRP antibody

Mouse monoclonal antibody against an uncarboxylated GRP epitope

Ref MA:UC50 · 50 µg · €465

Snapshot

Catalog numberMA:UC50
TargetHuman undercarboxylated Gla-rich protein (ucGRP)
Host and clonalityMouse, monoclonal
ReactivityHuman
ApplicationsImmunolocalization, immunofluorescence
Quantity and form50 µg, lyophilized
PurityAffinity purified
Storage-20 °C short term, -80 °C long term

What it is for

GRP carries a high density of potential γ-carboxylation sites across its sequence, and the extent and distribution of carboxylation in native GRP remain largely undefined. No single antibody can resolve the overall carboxylation status of full-length GRP. Antibodies raised against individual carboxylation-sensitive epitopes are therefore the practical way to study epitope-specific GRP carboxylation in biological samples.

MA:UC50 recognizes an uncarboxylated epitope of human GRP and does not cross-react with the corresponding γ-carboxylated peptide. Specificity was demonstrated with the matched synthetic peptides and by the distinct staining patterns obtained against MA:C50 in tissue.

  • Comparative tissue localization using the matched MA:UC50 and MA:C50 pair
  • Assessment of GRP epitope carboxylation patterns in human tissues

Validated applications

ApplicationSample typeRecommended concentration
ImmunolocalizationHuman tissues and cells5 µg/ml
ImmunofluorescenceHuman tissues and cells5 µg/ml

Optimize for your application.

Handling

Reconstitute with 50 µL sterile protease-free water for a final concentration of 1 µg/µL, by gentle rotation at 4 °C for at least 12 hours.

Shipped at room temperature, lyophilized.

After reconstitution store at -20 °C for up to two months. For long term storage use -80 °C.

Avoid repeated freeze-thaw cycles.

Key references

  • Viegas CS et al. (2014). Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interaction. BioMed Res Int 2014:340216. https://doi.org/10.1155/2014/340216
  • Cavaco S et al. (2016). Gla-rich protein is involved in the cross-talk between calcification and inflammation in osteoarthritis. Cell Mol Life Sci 73(5):1051-1065. https://doi.org/10.1007/s00018-015-2033-9
  • Viegas CS et al. (2015). Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Arterioscler Thromb Vasc Biol 35(2):399-408. https://doi.org/10.1161/ATVBAHA.114.304823

The complete reference list is in the datasheet.

For research use only. Not intended for diagnostic, therapeutic or commercial use. Based on PCT patent application PCT/PT2009000046, owned by the University of Algarve and CCMAR, licensed to GenoGla Diagnostics.

Related products